View in EDS

Low-dose DOX-polygodial nanosystem modulates the CD47/CALR axis for safer triple negative breast cancer treatment.

Saved in:
Bibliographic Details
Title: Low-dose DOX-polygodial nanosystem modulates the CD47/CALR axis for safer triple negative breast cancer treatment.
Authors: Emara HM; Nanotechnology Program, School of Sciences & Engineering, The American University in Cairo New Cairo 11835 Egypt Nageh.allam@aucegypt.edu., Youness RA; Molecular Biology and Biochemistry Department, Molecular Genetics Research Team, Faculty of Biotechnology, German International University (GIU) New Administrative Capital 11835 Egypt., Manie TM; Breast Surgery Department, National Cancer Institute, Faculty of Medicine, Cairo University Cairo Egypt., Abdelnaser A; Institute of Global Health and Human Ecology, School of Sciences and Engineering, AUC - American University in Cairo New Cairo Egypt anwar.abdelnaser@aucegypt.edu., Allam NK; Nanotechnology Program, School of Sciences & Engineering, The American University in Cairo New Cairo 11835 Egypt Nageh.allam@aucegypt.edu.; Energy Materials Laboratory, Physics Department, School of Sciences & Engineering, The American University in Cairo New Cairo 11835 Egypt.
Source: Nanoscale advances [Nanoscale Adv] 2026 Feb 19; Vol. 8 (7), pp. 2333-2350. Date of Electronic Publication: 2026 Feb 19 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101738708 Publication Model: eCollection Cited Medium: Internet ISSN: 2516-0230 (Electronic) Linking ISSN: 25160230 NLM ISO Abbreviation: Nanoscale Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41788762
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Low-dose DOX-polygodial nanosystem modulates the CD47/CALR axis for safer triple negative breast cancer treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Emara+HM%22">Emara HM</searchLink>; Nanotechnology Program, School of Sciences & Engineering, The American University in Cairo New Cairo 11835 Egypt Nageh.allam@aucegypt.edu.<br /><searchLink fieldCode="AU" term="%22Youness+RA%22">Youness RA</searchLink>; Molecular Biology and Biochemistry Department, Molecular Genetics Research Team, Faculty of Biotechnology, German International University (GIU) New Administrative Capital 11835 Egypt.<br /><searchLink fieldCode="AU" term="%22Manie+TM%22">Manie TM</searchLink>; Breast Surgery Department, National Cancer Institute, Faculty of Medicine, Cairo University Cairo Egypt.<br /><searchLink fieldCode="AU" term="%22Abdelnaser+A%22">Abdelnaser A</searchLink>; Institute of Global Health and Human Ecology, School of Sciences and Engineering, AUC - American University in Cairo New Cairo Egypt anwar.abdelnaser@aucegypt.edu.<br /><searchLink fieldCode="AU" term="%22Allam+NK%22">Allam NK</searchLink>; Nanotechnology Program, School of Sciences & Engineering, The American University in Cairo New Cairo 11835 Egypt Nageh.allam@aucegypt.edu.; Energy Materials Laboratory, Physics Department, School of Sciences & Engineering, The American University in Cairo New Cairo 11835 Egypt.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101738708%22">Nanoscale advances</searchLink> [Nanoscale Adv] 2026 Feb 19; Vol. 8 (7), pp. 2333-2350. <i>Date of Electronic Publication: </i>2026 Feb 19 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Royal+Society+of+Chemistry%22">Royal Society of Chemistry </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101738708 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2516-0230 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225160230%22">25160230 </searchLink><i>NLM ISO Abbreviation: </i>Nanoscale Adv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41788762
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1039/d5na01082a
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2333
    Titles:
      – TitleFull: Low-dose DOX-polygodial nanosystem modulates the CD47/CALR axis for safer triple negative breast cancer treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Emara HM
      – PersonEntity:
          Name:
            NameFull: Youness RA
      – PersonEntity:
          Name:
            NameFull: Manie TM
      – PersonEntity:
          Name:
            NameFull: Abdelnaser A
      – PersonEntity:
          Name:
            NameFull: Allam NK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 02
              Text: 2026 Feb 19
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2516-0230
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Nanoscale advances
              Type: main
ResultId 1